Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-09-08 00:00:00 ET · period of report 2025-09-04 · accession 0001415889-25-023874 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-08 | 2025-09-04 | KNSA | Moat Ross | CHIEF CORP, COMM. Off | S - Sale | $35.31 | -3,523 | 9,415 | -27% | -$124.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-09-04 | S | D | 3,523 | $35.31 | 9,415 | D | — | — |